Novartis’ recently departed oncology R&D chief is headed back to Dana-Farber and a new job in cancer research
The revolving door at Novartis has spit out another top executive, only this one is headed back to a faculty post at Dana-Farber Cancer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
